Bard Associates’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Buy
805
+12
+2% +$2.08K 0.02% 160
2026
Q1
$157K Buy
793
+708
+833% +$165K 0.04% 145
2025
Q4
$22.9K Buy
+85
New +$21.6K 0.01% 174

Other funds holding ACN

Bard Associates's ACN Position: Q2 2026 in Review

Bard Associates increased its Accenture (ACN) stake by 1.5% in Q2 2026, buying an estimated $2.08K and bringing the position to 805 shares worth $100K. The position accounts for 0.02% of the portfolio, ranked #160.

Bard Associates first reported a position in ACN in Q4 2025 and has held it in 3 quarters since. The position peaked at $157K in Q1 2026. 1,893 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Bard Associates held 805 shares of Accenture worth $100K as of Q2 2026.
  • Bard Associates bought 12 Accenture shares in Q2 2026, an estimated $2.08K.
  • Accenture made up 0.02% of Bard Associates's portfolio in Q2 2026, its #160 holding.
  • Bard Associates first reported a position in Accenture in Q4 2025 and has held it in 3 quarters since.
  • Bard Associates's Accenture position peaked at $157K in Q1 2026.
  • 1,893 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.